Skip to main content
Noma survivors: closer to getting the attention they deserve

Neglected diseases

Neglected diseases disproportionally affect people in the world’s least-developed countries and there are few tools available with which to diagnose and treat.

They cover neglected tropical diseases, such as kala azar (visceral leishmaniasis) and sleeping sickness (human African trypanosomiasis), plus issues such as snakebite envenoming, but also Chagas, noma, cutaneous leishmaniasis, and others.

These diseases are considered ‘neglected’, as – although they are usually life-threatening and claim thousands of lives every year – the pharmaceutical and diagnostic industries ignore the development of vaccines, diagnostic tools and drugs to tackle them.

Neglected diseases

 
Sleeping sickness

Supply of sleeping sickness drugs confirmed

Press Release 3 May 2001
 
Neglected diseases

International Conference on Stimulating Research and Development for Neglected Diseases

Project Update 26 Apr 2001
 
Republic of Congo

Sleeping sickness in Congo-Brazzaville possibly at epidemic proportions

Project Update 23 Apr 2001
 
Republic of Congo

Rehabilitation in Congo-Brazzaville opens way to sleeping-sickness programme

Project Update 18 Mar 2001
 
Sleeping sickness

A brief profile on sleeping sickness

Project Update 1 Jan 2001
 
Neglected diseases

Nobel funds allocated to neglected diseases

Press Release 21 Nov 2000
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site